+ -Text Size

Peer Review Committee for Leukemia, Immunology and Blood Cell Development (LIB)

Areas reviewed: Studies dealing with leukemia, lymphomas, other hematologic malignancies and immunology, the hematopoietic system and the control of the development and differentiation of erythroid, myeloid, and lymphoid blood cells. Studies involving platelets, coagulation, the complement system, and the biology of the immune system including cell types, cytokines, antigen processing, antibody molecules, immune tolerance and deficiencies. Preclinical therapeutic studies include chemotherapy, immunotherapeutic approaches and bone marrow transplantation. Related clinical research training grants and clinical research professorships are included.

Robert L. Redner, MD, Chair 
University of Pittsburgh, Pittsburgh, PA

Rebecca Chan, MD, PhD, Vice Chair
Indiana University, Indianapolis, IN

JoAnn Aguirre, Stakeholder
Keaau, HI

Richard E. Dahl, PhD
University of New Mexico. Albuquerque, NM

Stephen Gottschalk, MD
Baylor College of Medicine, Houston, TX

Susanna Greer, PhD
Georgia State University, Atlanta, GA

Gary K. Koski, PhD 
Kent State University, Kent, OH

Paul P. Liu, MD, PhD
NIH/National Human Genome Research Institute, Bethesda, MD

John Ohlfest, PhD
University of Minnesota - Twin Cities, Minneapolis, MN

John R. Ortaldo, PhD
National Cancer Institute, Frederick, MD

Carolee Polek, Stakeholder
Newark, DE

Todd D. Schell, PhD
Pennsylvania State University, Hershey, PA

Charles L. Sentman, PhD
Dartmouth Medical School, Lebanon, NH

Michael R. Shurin, MD, PhD
University of Pittsburgh, Pittsburgh, PA

Michael H. Tomasson, MD
Washington University, St. Louis, MO

Yong-Guang Yang, MD, PhD
Columbia University, New York, NY